Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro

Neurobiology of Aging

Volumn 17, Issue 1, 1996, Pages 107-113

  Wujek, Jerome R ^a   Dority, Michael D ^a   Frederickson, Robert C A ^a   Brunden, Kurt R ^a  

^a GUILFORD PHARMACEUTICALS INC   (United States)

Author keywords

Alzheimer's disease; Amyloid fibrils; Amyloid ; In vitro; Neurite outgrowth; Neuronal adhesion; Neurotoxicity; Neurotrophic; Senile plaques; Serum free media; Substrate

Indexed keywords

AMYLOID BETA PROTEIN; POLYLYSINE; POLYORNITHINE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN CORTEX; FIBER; HIPPOCAMPUS; IN VITRO STUDY; NERVE CELL CULTURE; NERVE GROWTH; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SENILE PLAQUE;

EID: 0029670992     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(95)02020-9     Document Type: Article

References (51)

1. Bottenstein, J. E.; Sato, G. H. Growth of a rat neuroblastoma cell line in serum-free supplemented medium. Proc. Natl. Acad. Sci. USA 76:514-517; 1979.
2. Brewer, G. J.; Torricelli, J. R.; Evege, E. K.; Price, P. J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal™, a new serum-free medium combination. J. Neurosci. Res. 35:567-576; 1993.
3. Brun, A. An overview of light and electron microscopic changes. In: B. Reisberg, ed. Alzheimer's disease: The standard reference. New York: The Free Press; 1983:37-47.
4. Brunden, K. R.; Frederickson, R.C.A. New opportunities in AD research-roles of immunoinflammatory responses and glia. Alzheimer's Disease and Associated Disorders 8:159-165; 1994.
5. Busciglio, J.; Lorenzo, A.; Yankner, B. A. Methodological variables in the assessment of beta-amyloid neurotoxicity. Neurobiol. Aging 13:609-612; 1992.
6. Cai, X-D; Golde, T. E.; Younkin, S. G. Release of excess amyloid protein from a mutant amyloid protein precursor. Science 259:514-516; 1993.
7. Canning, D. R.; McKeon, R. J.; DeWitt, D. A., Perry, G., Wujek, J. R.; Frederickson, R. C. A.; Silver, J. β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth. Exp. Neurol. 124:289-298; 1993.
8. Citron, M.; Oltersdorf, T.; Haass, C.; McConlogue, L.; Hung, A. Y.; Seubert, P.; Vigo-Pelfrey, C.; Lieberburg, I.; Selkoe, D. J. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672-674; 1992.
9. Cotman, C. W.; Pike, C. J.; Copani, A. β-Amyloid neurotoxicity: A discussion of in vitro findings. Neurobiol. Aging 13:587-590; 1992.
10. Duffy, P. E.; Rapport, M.; Graf, L. Glial fibrillary acid protein and Alzheimer-type senile dementia. Neurology 30:778-782; 1980.
11. Fraser, P. E.; Lévesque, L.; McLachlan, D. R. Alzheimer A amyloid forms an inhibitory neuronal substrate. J. Neurochem. 62:1227-1230; 1994.
12. Frederickson, R. C. A. Astroglia in Alzheimer's disease. Neurobiol. Aging 13:239-253; 1992.
13. Glenner, G. G.; Wong, C. W. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Comm. 122:1131-1135; 1984.
14. Goate, A.; Chartier-Harlin, M.-C.; Mullan, M.; Brown, J.; Crawford, F.; Fidani, L.; Giuffra, L.; Haynes, A.; Irving, N.; James, L.; Mant, R.; Newton, P.; Rooke, K.; Roques, P.; Talbot, C.; Pericak-Vance, M.; Roses, A.; Williamson, R.; Rossor, M.; Owen, M.; Hardy, J. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704-706; 1991.
15. Griffin, W. S. T.; Stanley, L. C.; Ling, C.; White, L.; MacLeod, V.; Perrot, L. J.; White, C. L., III; Araoz, C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA 86:7611-7615; 1989.
16. Haga, S.; Ikeda, K.; Sato, M.; Ishii, T. Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601:88-94; 1993.
17. Hardy, J. ; Allsop, D. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Psychopharmacol. 12:383-388; 1991.
18. Hensley, K.; Carney, J. M.; Mattson, M. P.; Adsenova, M.; Harris, M.; Wu, J. F.; Floyd, R. A.; Butterfield, D. A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: Relevance to Alzheimer's disease. Proc. Natl. Acad. Sci. USA 91:3270-3274; 1994.
19. Itagaki, S.; McGeer, P. L.; Akiyama, H.; Zhu, S.; Selkoe, D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J. Neuroimmunol. 24:173-182; 1989.
20. Jacobsen, J. S.; Blume, A. J.; Vitek, M. P. Quantitative measurement of alternatively spliced amyloid precursor protein mRNA expression in Alzheimer's disease and normal brain by S1 nuclease protection analysis. Neurobiol. Aging 12:585-592; 1991.
21. Koo, E. H.; Park, L.; Selkoe, D. J. Amyloid β-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc. Natl. Acad. Sci. USA 90:4748-4752; 1993.
22. Lippiello, P. M.; Fernandes, K. G. Identification of putative high affinity nicotinic receptors on cultured cortical neurons. J. Pharm. Exp. Ther. 246:409-416; 1988.
23. Mandybur, T. I.; Chuirazzi, C. C. Astrocytes and the plaques of Alzheimer's disease. Neurology 40:635-639; 1990.
24. Masters, C. L.; Simms, G.; Weinman, N. A.; Multhaup, G.; McDonald, B. L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA 82:4245-4249; 1985.
25. Mattson, M. P.; Cheng, B.; Davis, D.; Bryant, K.; Lieberburg, I.; Rydel, R. E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neuroscience 12:376-389; 1992.
26. Mattson, M. P.; Kater, S. B. Isolated hippocampal neurons in cryopreserved long-term cultures: Development of neuroarchitecture and sensitivity to NMDA. Int. J. Devl. Neuroscience 6:439-452; 1988.
27. McGeer, P. L.; Akiyama, H.; Itagaki, S.; McGeer, E. G. Activation of the classical complement pathway in brain tissue of Alzheimer patients. Neurosci. Lett. 107:341-346; 1989.
28. Mountjoy, C. Q.; Roth, M.; Evans, N. J.; Evans, H. M. Cortical neuronal counts in normal elderly controls and demented patients. Neurobiol. Aging 4:1-11; 1983.
29. Murrell, J.; Farlow, M.; Ghetti, B.; Benson, M. D. Aβ mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254:97-99; 1991.
30. Perlmutter, L. S.; Scott, S. A.; Barrón, E.; Chui, H. C. MHC class II-positive microglia in human brain: Association with Alzheimer lesions. J. Neurosci. Res. 33:549-558; 1992.
31. Pike, C. J.; Burdick, D.; Walencewicz, A. J.; Glabe, C. G.; Cotman, C. W. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state. J. Neurosci. 13:1676-1687; 1993.
32. Pike, C. J.; Cummings, B. J.; Cotman, C. W. β-Amyloid induces neuritic dystrophy in vitro: Similarities with Alzheimer pathology. NeuroReport 3:769-772; 1992.
33. Pike, C. J.; Walencewicz, A. J.; Glabe, C. G.; Cotman, C. W. In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 563:311-314; 1991.
34. Puchtler, H.; Sweat, F.; Levine, M. On the binding of Congo Red by amyloid. J. Histochem. Cytochem. 10:355-364; 1962.
35. Rogers, J.; Cooper, N. R.; Webster, S.; Schultz, J.; McGeer, P. L.; Styren, S. D.; Civin, W. H.; Brachova, L.; Bradt, B.; Ward, P.; Lieberburg, I. Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 89:10016-10020; 1992.
36. Selkoe, D. J. The molecular pathology of Alzheimer's disease. Neuron 6:487-498; 1991.
37. Seubert, P.; Vigo-Pelfrey, C.; Esch, F.; Lee, M.; Dovey, H.; Davis, D.; Sinha, S.; Schlossmacher, M.; Whaley, J.; Swindlehurst, C.; McCormack, R.; Wolfert, R.; Selkoe, D.; Lieberburg, I.; Schenk, D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327; 1992.
38. Shahar, A.; de Vellis, J.; Vernadakis, A.; Haber, B. A dissection and tissue culture manual of the nervous system. New York: Alan R. Liss; 1989.
39. Simmons, L. K.; May, P. C.; Tomaselli, K. J.; Rydel, R. E.; Fuson, K. S.; Brigham, E. F.; Wright, S.; Lieberburg, I.; Becker, G. W.; Brems, D. N.; Li, W. Y. Secondary structure of amyloid peptide correlates with neurotoxic activity in vitro. Mol. Pharm. 45:373-379; 1994.
40. 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66:223-230; 1992.
41. Suzuki, N.; Iwatsubo, T.; Odaka, A.; Ishibashi, Y.; Kitada, C.; Ihara, Y. High tissue content of soluble 1-40 is linked to cerebral amyloid angiopathy. Amer. J. Pathol. 145:452-460; 1994.
42. Terry, R.; Katzman, R. Senile dementia of the Alzheimer type: Defining a disease. In: Katzman, R. and Terry, R., eds. Neurology of aging. Philadelphia: F.A. Davis; 1983:51-84.
43. Terry, R. D.; Peck, A.; DeTeresa, R.; Schecter, R.; Horoupian, D. S. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann. Neurol. 10:184-192; 1981.
44. Whitson, J. S.; Selkoe, D. J.; Cotman, C. W. Amyloid protein enhances the survival of hippocampal neurons in vitro. Science 243:1488-1490; 1989.
45. Whitson, J. S.; Glabe, C. G.; Shintani, E.; Abcar, A.; Cotman, C. W. β-Amyloid protein promotes neuritic branching in hippocampal cultures. Neurosci. Lett. 110:319-324; 1990.
46. Wisniewski, H. M.; Terry, R. D. Reexamination of the pathogenesis of the senile plaque. In: H. M. Zimmerman, ed. Progress in neuropathology, vol. 2. New York: Grune & Stratton; 1973:1-26.
47. Wisniewski, K.; Wisniewski, H. M.; Wen, G. Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17:278-282; 1985.
48. Wujek, J. R.; Akeson, R. A. Extracellular matrix derived from astrocytes stimulates neuritic outgrowth from PC12 cells in vitro. Dev. Brain Res. 34:87-97; 1987.
49. Yankner, B. A.; Mesulam, M.-M. β-amyloid and the pathogenesis of Alzheimer's disease. N. Eng. J. Med. 325:1849-1857; 1991.
50. Yankner, B. A.; Dawes, L. R.; Fisher, S.; Villa-Komaroff, L.; Oster-Granite, M. L.; Neve, R. L. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's Disease. Science 245:417-420; 1989.
51. Yankner, B. A.; Duffy, L. K.; Kirschner, D. A. Neurotrophic and neurotoxic effects of amyloid protein: Reversal by tachykinin neuropeptides. Science 250:279-282; 1990.